Our results demonstrate that the whole-body loss of cIAP1 (and not cIAP2), which is a critical, positive regulator of NF-κB signaling, can attenuate denervation-induced muscle atrophy as demonstrated by reduced muscle loss and decreased Atrogin-1 and MuRF1 expression. This evidence concerns the gene BIRC2 and muscle atrophy.